Canaccord Genuity Reiterates Buy on Axogen, Maintains $11 Price Target
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Caitlin Cronin has reiterated a Buy rating on Axogen (NASDAQ:AXGN) and maintained the price target of $11.

December 07, 2023 | 3:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity analyst Caitlin Cronin reiterates a Buy rating on Axogen with a maintained price target of $11.
The reiteration of a Buy rating by a Canaccord Genuity analyst, along with the maintenance of a price target, typically signals confidence in the company's future performance. This endorsement may positively influence investor sentiment and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100